Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Biotech stock Neurogene collapsed Tuesday after a patient experienced a serious side effect in the company's Rett syndrome ...

Last year, biotech shutdowns spiked. Thankfully, 2024’s numbers are a little lower, dropping from the 27 closures in 2023 to 22 this year.

or “the master regulator of immune tolerance,” according to the biotech. Tolerance touts an allogeneic thymus induced pluripotent stem cell (iPSC)-based cell therapy platform, plus other ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

According to McKinsey, one biotech platform category of considerable investor interest is 'new delivery methods that can send novel therapies to the entire affected tissue precisely and safely.' ...

Purple Biotech (PPBT) announced new data regarding its tri-specific antibody platform, CAPTN-3, which were presented at the 36th European Organization for Research and Treatment of Cancer ...

About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 ...

We believe the features of our technology and platform-based approach allow us to accelerate ... lead to improved safety and better outcomes for patients.” Araris Biotech is a pioneering leader in the ...

Press Release: Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate Platform in ChemBioChem First characterization of its novel conjugation technology for creating ...